These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 493172)

  • 1. [Neurological complications after treatment with Kenalog].
    Mazurkowa K; Kudybka E; Wojczuk J; Mazanek-Szymańska E; Gasińska T
    Pol Tyg Lek; 1979 Jul; 34(29):1165-6. PubMed ID: 493172
    [No Abstract]   [Full Text] [Related]  

  • 2. Local atrophy following triamcinolone injection.
    Dyment PG
    Pediatrics; 1970 Jul; 46(1):136-7. PubMed ID: 5423443
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Subcutaneous atrophy following intramuscular administration of triamcinalone acetonide.
    Steffey JM
    Am J Dis Child; 1973 Oct; 126(4):561-2. PubMed ID: 4783670
    [No Abstract]   [Full Text] [Related]  

  • 4. Local subcutaneous atrophy after corticosteroid injection.
    Jacobs MB
    Postgrad Med; 1986 Sep; 80(4):159-60. PubMed ID: 3763512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroneal muscular atrophy. Electronmicroscopic studies.
    Gallai M
    Neuropatol Pol; 1982; 20(1-2):129-35. PubMed ID: 7183920
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of excessive doses of Kenalog administered during short periods of time].
    Mazanek-Szmańska E; Gasińska T; Starzewska H; Stokłosa M; Beldzik A; Kowalski S; Potyrcha H; Smolarek J; Zalewski J; Kudybka E
    Pol Tyg Lek; 1979 Jun; 34(25):997-1001. PubMed ID: 471835
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relationship between locally administered Kenalog and subcutaneous ruptures of tendons (author's transl)].
    Koudela K; Solc J; Douda L; Pazdera M
    Acta Chir Orthop Traumatol Cech; 1980 Apr; 47(2):108-12. PubMed ID: 7386100
    [No Abstract]   [Full Text] [Related]  

  • 8. Finger tendon rupture following local application of triamcinolone-acetonide (Kenalog A-40).
    Jakubík J
    Acta Chir Plast; 1981; 23(3):180-8. PubMed ID: 6169243
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of Kenalog-40 in treating degenerative-dystrophic diseases of the locomotor apparatus].
    Mizak ST; Sennik VT
    Vestn Khir Im I I Grek; 1986 Jul; 137(7):91-4. PubMed ID: 3564304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rupture of the finger tendons after administration of triamcinolone acetonide (Kenalog A-40)].
    Jakubík J
    Rozhl Chir; 1981 Dec; 60(12):805-11. PubMed ID: 7336299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuropathies in cancer patients during chemotherapy with platinum preparations].
    Perevodchikova NI; Zavalishin IA; Adartseva LS; Sloka SA; Orel NF; Gorbunova VA; Brovtsyn VK
    Sov Med; 1991; (1):79-81. PubMed ID: 1862396
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucocorticoid-induced atrophy in different fibre types of selected rat jaw and hind-limb muscles.
    Roy RR; Gardiner PF; Simpson DR; Edgerton VR
    Arch Oral Biol; 1983; 28(7):639-43. PubMed ID: 6579895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kenalog-40 (triamcinolone acetonide) in the treatment of severe infectious-allergic bronchial asthma].
    Chachaj W; Malolepszy J; Ceiślińska ; Kuczńskasekieta K
    Pol Tyg Lek; 1975 Jun; 30(25):1077-9. PubMed ID: 1135088
    [No Abstract]   [Full Text] [Related]  

  • 14. [Polyneuropathy in acute intermittent porphyria].
    Szela S; Gogolewska I; Pliszka M; Was B
    Wiad Lek; 1989 Jul 1-15; 42(13-15):888-90. PubMed ID: 2634316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development and regression of dermal corticosteroid atrophy. 4. Concentration dependence of the skin thinning effect of triamcinolone acetonide].
    Lütgemeier MD; Lubach D
    Derm Beruf Umwelt; 1987; 35(2):55-7. PubMed ID: 2954806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The condition of the visual system in patients treated with excessive doses of Kenalog (author's transl)].
    Szymański J; Hałatek R; Mazanek-Szymańska E; Szaflik J
    Klin Oczna; 1981 Jun; 83(6):297-8. PubMed ID: 7289419
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sclerodermiform linear atrophy caused by triamcinolone].
    Rodríguez Prieto MA; Quiñones PA; Aragoneses H; Marino JM
    Med Cutan Ibero Lat Am; 1985; 13(4):353-6. PubMed ID: 3912638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the neurological status and EEG findings in workers chronically exposed to cadmium].
    MNusioł A; Szyrocka-Szwed K; Wojczuk J; Kudybka E
    Wiad Lek; 1981 Oct; 34(19):1615-20. PubMed ID: 7336724
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of triamcinolone acetonide in the treatment of severe intrinsic bronchial asthma.
    Romański B; Pawlik K; Wilewska-Klubo T
    Allergol Immunopathol (Madr); 1978; 6(4):321-4. PubMed ID: 735981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kenalog in the treatment of asthma].
    Ciszek J; Kazimierczak A; Walczak J
    Pneumonol Pol; 1976; 44(4):313-20. PubMed ID: 1264821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.